On the 25th, the net advertising company Ureru Netsu Koukokusha <9235> announced that its subsidiary Groups and Orlinku Pharmaceutical will undergo a merger with Groups as the surviving company and will change its business name.
Orlinku Pharmaceutical has largely increased the sales volume of each commodity etf sold, such as Kogao+, through the SNS marketing measures implemented by Groups. This time, Groups and Orlinku Pharmaceutical will merge on January 1, 2025 (scheduled) and change the business name to Orkus. Orlinku Pharmaceutical will be dissolved. This merger aims to transform into a more efficient organization and create an environment for rapid decision-making, leading to further growth.
The company aims to effectively utilize the management resources of the entire group and strengthen its management base through efficiency and rationalization.
